Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008;13(2):260-70.
doi: 10.2478/s11658-007-0054-6. Epub 2008 Apr 10.

Increased pressure stimulates aberrant dendritic cell maturation

Affiliations

Increased pressure stimulates aberrant dendritic cell maturation

David H Craig et al. Cell Mol Biol Lett. 2008.

Abstract

Patients with malignancy typically exhibit abnormal dendritic cell profiles. Interstitial tumor pressure is increased 20-50 mmHg over that in normal tissue. We hypothesized that elevated pressure in the tumor microenvironment may influence dendritic cell (DC) phenotype and function. Monocyte-derived immature and mature DC isolated from healthy human donors were exposed to either ambient or 40 mmHg increased pressure at 37 degrees C for 12 hours, then assessed for expression of CD80, CD86, CD83, CD40, MHC-I and MHC-II. IL-12 production and phagocytosis of CFSE-labeled tumor lysate were assessed in parallel. Elevated pressure significantly increased expression of all co-stimulatory and MHC molecules on mature DC. Immature DC significantly increased expression of CD80, CD86, CD83 and MHC-II, but not MHC-I and CD40, versus ambient pressure controls. Pressure-treated immature DC phenotypically resembled mature DC controls, but produced low IL-12. Phenotypic maturation correlated with decreased phagocytic capacity. These results suggest increased extracellular pressure may cause aberrant DC maturation and impair tumor immunosurveillance.

PubMed Disclaimer

Similar articles

Cited by

References

    1. de Visser K.E., Eichten A., Coussens L.M. Paradoxical roles of the immune system during cancer development. Nat. Rev. Cancer. 2006;6:24–37. doi: 10.1038/nrc1782. - DOI - PubMed
    1. Gabrilovich D. Mechanisms and functional significance of tumour-induced dendritic-cell defects. Nat. Rev. Immunol. 2004;4:941–952. doi: 10.1038/nri1498. - DOI - PubMed
    1. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature. 1998;392:245–252. doi: 10.1038/32588. - DOI - PubMed
    1. Satthaporn S., Robins A., Vassanasiri W., El-Sheemy M., Jibril J.A., Clark D., Valerio D., Eremin O. Dendritic cells are dysfunctional in patients with operable breast cancer. Cancer Immunol. Immunother. 2004;53:510–518. doi: 10.1007/s00262-003-0485-5. - DOI - PMC - PubMed
    1. Garrity T., Pandit R., Wright M.A., Benefield J., Keni S., Young M.R. Increased presence of CD34+ cells in the peripheral blood of head and neck cancer patients and their differentiation into dendritic cells. Int. J. Cancer. 1997;73:663–669. doi: 10.1002/(SICI)1097-0215(19971127)73:5<663::AID-IJC9>3.0.CO;2-V. - DOI - PubMed

Publication types